1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2026Current Knowledge on Atypical Parathyroid Tumors and Emerging Strategies for Risk Stratification Endocrinology and Metabolism(대한내분비학회지)
2026Erythropoiesis-Stimulating Agents and Development of Cancer Among Patients Receiving DialysisJAMA NETWORK OPEN
2026Prior Cancer and Survival in Patients With Esophageal Squamous Cell CarcinomaJAMA NETWORK OPEN
2026Overall survival for amivantamab plus lazertinib versus osimertinib as first-line treatment in Asian participants with EGFR-mutant advanced NSCLC: A MARIPOSA subset analysis LUNG CANCER
2026Surrogate endpoints for survival in KEYNOTE-585: neoadjuvant/adjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy for gastric or gastroesophageal junction adenocarcinoma ESMO OPEN
2026Role of endoscopic ultrasonography in differential diagnosis of gallbladder wall thickening: a multi-center retrospective studyHPB
2026Diabetes Fact Sheet 2025: Comparative Epidemiology and Clinical Features of Obese and Non-Obese Diabetes in Korea DIABETES & METABOLISM JOURNAL
2026Reply to "Renal Dysfunction, Arterial Stiffness, and the Interpretation of 'Global Afterload' in Moderate Aortic Stenosis - What's Old is New AgainJOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
2026Association between deep learning-based atrial fibrillation burden and in-hospital mortality PLOS DIGITAL HEALTH
2026Impact of Sarcopenia on Renal Outcomes in Patients with Septic Acute Kidney Injury: A Retrospective Cohort Study YONSEI MEDICAL JOURNAL
2026Diabetes Fact Sheet 2025: Special Edition on Diabetes with Obesity and in Pregnancy DIABETES & METABOLISM JOURNAL
2026Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): final report KIDNEY RESEARCH AND CLINICAL PRACTICE
2026Effect of Antidiabetic Drug Classes on the Risk of Liver-Related Events in Individuals With T2D and MASLDCLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2026First-Line Sacituzumab Govitecan Plus Pembrolizumab in Metastatic NSCLC: PD-L1 TPS Less Than 50% and More Than or Equal to 50% Cohorts of the EVOKE-02 StudyJOURNAL OF THORACIC ONCOLOGY
2026Analytical and clinical validation of CancerMaster, an automated targeted NGS panel, for tumor-only precision oncology SCIENTIFIC REPORTS
2026Atypical protein kinase C activation drives intestinal glucose excretion in diabetes mellitus NATURE COMMUNICATIONS
2026Effect of COVID-19 pandemic on ART access and timely initiation in people living with HIV in 31 countries: a regression discontinuity design study BMJ OPEN
2026Nivolumab plus chemotherapy in Asian people with advanced or recurrent stomach or gastroesophageal junction cancer (ATTRACTION-4 study): a plain language summaryFUTURE ONCOLOGY
2026Efficacy and Safety of Capivasertib (AZD5363), a Potent, Oral Pan-AKT Inhibitor, in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (CAPITAL)CLINICAL CANCER RESEARCH
2026Domain-Specific Paradox of Physical Activity and Depression Among Patients With Cardiovascular Disease or Related ConditionsJOURNAL OF THE AMERICAN HEART ASSOCIATION

Recent Submissions

Browse

Links